Reversal of hypertriglyceridemia in diabetic BTBR ob/ob mice does not prevent nephropathy
- 28 April 2021
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 101 (7) , 935-941
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Antisense Oligonucleotide Inhibition of Apolipoprotein C-III Reduces Plasma Triglycerides in Rodents, Nonhuman Primates, and HumansCirculation Research, 2013
- Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation studyThe Lancet, 2012
- Lipid-Induced Mitochondrial Stress and Insulin Action in MuscleCell Metabolism, 2012
- BTBR Ob/Ob Mutant Mice Model Progressive Diabetic NephropathyJournal of the American Society of Nephrology, 2010
- Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humansJournal of Clinical Investigation, 2009
- The role of innate immunity in atherogenesisJournal of Lipid Research, 2009
- Prevalence of Diabetes Complications in Adolescents With Type 2 Compared With Type 1 DiabetesDiabetes Care, 2006
- Higher incidence of diabetic nephropathy in type 2 than in type 1 diabetes in early-onset diabetes in JapanKidney International, 2000
- Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.Journal of Clinical Investigation, 1997
- Disparities in Incidence of Diabetic End-Stage Renal Disease According to Race and Type of DiabetesNew England Journal of Medicine, 1989